Market Data & News

Benzinga: Four Paid Products Behind One Free News Site

What it actually sells beyond Benzinga Pro, and how its options coverage pairs with automated execution.

Market Data & News · 6 min read

Benzinga

The hook: Benzinga's cannabis section, the vertical that arguably built its early reputation, now returns an explicit "Gone" error. Meanwhile it quietly runs four separate paid products: Pro, a $10.75/month Edge tier, a login-gated Research product, and an institutional API business serving North American brokerages.

  • Founded 2010, ~25 million readers a month, HQ in Detroit
  • Four distinct paid products, not just Benzinga Pro
  • Contributor network appears to be unpaid, visibility-only
25M
Monthly Readers
4
Paid Products
$37+
Pro Starting Price

About Benzinga

Benzinga, operated under the legal name Accretive Capital LLC, launched in 2010 out of Detroit, Michigan, and now attracts roughly 25 million readers a month according to its own about page, with syndication partners including MSN, Bloomberg, Yahoo, and Robinhood. No individual founder or leadership names are published anywhere on its public site, an unusual omission for a media company its size.

Its monetization goes well beyond the Benzinga Pro terminal most traders know it for. There are four distinct paid products: Benzinga Pro (the real-time news terminal), Benzinga Edge (a cheaper $10.75/month retail product with congressional trade tracking and "done-for-you" model portfolios), Benzinga Research (a login-gated area), and a full institutional API business selling newswire feeds and datasets like insider trades, SEC filings, and unusual options activity directly to brokerages.

Its cannabis coverage, once a defining vertical, is now gone. The URL returns an explicit "Gone" status rather than a 404, indicating a deliberate removal, and there's no cannabis link anywhere in current site navigation. Crypto and fintech coverage remain active.

What Benzinga Offers

Benzinga Pro

Real-time terminal, three tiers from $37 to $197/month, with a 14-day free trial.

Benzinga Edge

A $10.75/month retail product with government trade tracking and model portfolios.

Unusual Options Activity

A live, continuously updating calendar of abnormal options volume.

Benzinga APIs

An institutional data business selling newswire and dataset access to brokerages.

Contributor Network ("BZContributors")

Byline articles distributed through Benzinga's syndication reach.

Benzinga AI

A newly added AI research tool exclusive to the Essential Pro tier.

Why Traders Rely On Benzinga

Its appeal comes down to speed and breadth. A single feed surfaces the catalysts, ratings changes, and unusual volume that move markets, often before slower outlets catch up, which is why it's become a default source for day traders scanning for the next setup rather than a supplementary read.

A media brand that quietly discontinued the vertical it was once best known for, while building an institutional API business most retail readers never see.

Benzinga: Strengths and Limitations

Strengths

Genuinely fast, broad breaking-news coverage
Multiple price points, from free news to a $10.75/mo retail tier to a full Pro terminal
Serious institutional data business behind the consumer-facing site

Limitations

No founder or leadership names published anywhere on-site
Contributor program appears to offer visibility only, no pay
Cannabis coverage, once a core identity, has been quietly discontinued

Benzinga FAQ

Three tiers: Basic at $37/month, Streamlined at $147/month, and Essential (with Benzinga AI) at $197/month, each with a 14-day free trial.

No. Benzinga also sells Benzinga Edge at $10.75/month, a login-gated Benzinga Research product, and a full institutional data and API business.

No, its cannabis section has been discontinued; the URL now returns an explicit "Gone" status and there's no cannabis link in current site navigation.

The published guidelines describe it entirely in terms of visibility and portfolio-building, with no compensation terms mentioned, suggesting it's an unpaid, exposure-based model.

Related tool

Automating a Benzinga Catalyst with PickMyTrade

Benzinga readers are often first to catch a catalyst, an earnings beat, an analyst upgrade, an unusual options print. The gap between spotting the move and getting filled is where most of a day trader's edge disappears. Build the alert once in TradingView based on the setup, and PickMyTrade routes it straight to a broker or funded account.

10,000+ Active Traders 5M+ Trades Processed Sub-200ms Execution 5-Day Free Trial · No Card Required

How it works

  • Build a TradingView alert around the setup, no coding required
  • Connect PickMyTrade to your broker or prop firm account once
  • PickMyTrade executes automatically when the alert fires
  • Copy the same signal across multiple accounts at once

No, PickMyTrade automates from TradingView alerts, not Benzinga's data feeds, even though Benzinga does sell that data separately to institutional clients.

Only indirectly, a trader would need to translate a portfolio's underlying rule into a TradingView alert condition; PickMyTrade doesn't read Edge's portfolios directly.

PickMyTrade is an independent automation platform. It is not affiliated with, endorsed by, or sponsored by Benzinga, unless otherwise stated. Trading futures and other leveraged products carries substantial risk of loss. Pricing and product details reflect what was published on Benzinga's official site at the time of research and may have changed since.